The largest database of trusted experimental protocols

3 protocols using anti cd3 apc cyanine7

1

ART Suppression of HIV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
To demonstrate that the cocktail of ART used in this study was fully suppressive, PBMC-derived CD4+ T cells from HIV-seronegative donors were activated for 2 days with RP10 containing 10 μg PHA (PeproTech) and 100 IU/mL IL2 (Thermofisher), washed with RP10, and then cultured in 20 IU/mL IL2 for one additional day. The cells were then either left untreated, or pretreated for 1 hr with an ART cocktail consisting of 5 μM AZT, 5 μM Ritonavir, 8 nM Efavirenz, 10 μM Lamivudine, 50 nM Raltegravir, and 0.5 μg/mL T-20 (all from NIH AIDS reagent program). Cells were then cultured for 4 days at a concentration of 2 × 106 cells/mL with RP10 alone or in the presence of 250 ng/mL p24Gag F4.GFP in RP10 containing 20 IU/mL IL2. The cells were then stained for 30 min at 4°C at a concentration of 106 cells/well in FACS buffer, with anti-CD3 APC/Cyanine7, anti-CD4 PE/Cy7, anti-CD8 Alexa Fluor 700, and Zombie Aqua as a Live/Dead discriminator (all from Biolegend). The cells were then washed three times with FACS buffer and fixed overnight in 2% PFA (Electron Microscopy Sciences). The cells were analyzed on an LSRII (BD Biosciences) and Flowjo software was used to gate on live, singlet CD3+CD8- cells and infection rates in these cells were monitored by GFP expression.
+ Open protocol
+ Expand
2

Comprehensive Immune Cell Profiling in Tumor Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FACSCanto II flow cytometer (BD Biosciences) was used to detect immune cells in tumor tissues. Single-cell suspensions of tumors were prepared according to the method described by Weigmann et al. [73 (link)]. To analyze CD8+ T cells (CD8+CD3+) and CD4+ T cells (CD4+CD3+), cells were stained with anti-CD3-APC/Cyanine7, anti-CD4-FITC, and anti-CD8-PE antibodies (Biolegend) following the manufacturer’s instructions. For macrophage polarization, cells were stained with anti-CD206-FITC, anti-CD11b-PE, anti-CD86-PE/Cyanine7, and anti-F4/80->Alexafluor 647 antibodies (Biolegend). CD11b+F4/80+CD86+ and CD11b+F4/80+CD206+ cells were defined as M1 and M2 macrophages, respectively. To analyze DC cells (CD11c+CD80+CD86+), cells were stained with anti-CD11c-FITC, anti-CD80-PE, and anti-CD86-PE/Cyanine7 antibodies (Biolegend). To analyze MDSCs (CD11b+Gr-1+), cells were stained with anti-CD11b-PE/Cyanine7 and anti-Gr-1-APC antibodies (Biolegend). Flow cytometry data analysis was conducted using FlowJo 10.8.1 software.
+ Open protocol
+ Expand
3

Validating ART Cocktail Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
To demonstrate that the cocktail of ART used in this study was fully suppressive, PBMCderived CD4+ T cells from HIV-seronegative donors were activated for 2 days with RP10 containing 10 μg PHA (PeproTech) and 100 IU/ml IL2 (Thermofisher), washed with RP10, and then cultured in 20 IU/ml IL2 for one additional day. The cells were then either left untreated, or pretreated for 1 h with an ART cocktail consisting of 5 μM AZT, 5 μM Ritonavir, 8 nM Efavirenz, 10 μM Lamivudine, 50 nM Raltegravir, and 0.5 µg/ml T-20 (all from NIH AIDS reagent program).
Cells were then cultured for 4 days at a concentration of 2x10 6 cells/ml with RP10 alone or in the presence of 250 ng/ml p24 Gag F4.GFP in RP10 containing 20 IU/ml IL2. The cells were then stained for 30 minutes at 4°C at a concentration of 10 6 cells/well in FACS buffer, with anti-CD3 APC/Cyanine7, anti-CD4 PE/Cy7, anti-CD8 Alexa Fluor 700, and Zombie Aqua as a Live/Dead discriminator (all from Biolegend). The cells were then washed 3 times with FACS buffer and fixed overnight in 2% PFA (Electron Microscopy Sciences). The cells were analyzed on an LSRII (BD Biosciences) and Flowjo software was used to gate on live, singlet CD3+CD8-cells, and infection rates in these cells were monitored by GFP expression.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!